These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 996286)

  • 1. The discriminative stimulus properties of nicotine, d-amphetamine and morphine in dopamine depleted rats.
    Rosecrans JA; Chance WT; Schechter MD
    Psychopharmacol Commun; 1976; 2(4):349-56. PubMed ID: 996286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discriminative stimulus properties of morphine in female rats chronically depleted of dopamine.
    Spencer RM; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):1-14. PubMed ID: 877397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-induced behavioral disruption in rats chronically depleted of brain dopamine.
    Kallman MJ; Spencer RM; White AT; Chance WT; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):115-25. PubMed ID: 571130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine and methadone-induced antinociception in rats permanently depleted of brain dopamine.
    Rosecrans JA; Elchisak MA; Harry GJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):287-300. PubMed ID: 596981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
    Vezina P; Blanc G; Glowinski J; Tassin JP
    J Pharmacol Exp Ther; 1992 May; 261(2):484-90. PubMed ID: 1578364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discriminative stimulus properties of D-amphetamine: a neuropharmacological review].
    Inagawa K
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):151-65. PubMed ID: 1414035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
    Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of some drugs of abuse on the discriminative stimulus properties of amphetamine.
    Druhan JP; Fibiger HC; Phillips AG
    Behav Pharmacol; 1991 Nov; 2(4 And 5):391-403. PubMed ID: 11224082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine, nicotine and mecamylamine share stimulus properties in the preexposure conditioned taste aversion procedure.
    Kunin D; Bloch RT; Smith BR; Amit Z
    Psychopharmacology (Berl); 2001 Dec; 159(1):70-6. PubMed ID: 11797072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of tolerance, recovery from tolerance and cross-tolerance for cocaine used as a discriminative stimulus.
    Wood DM; Emmett-Oglesby MW
    J Pharmacol Exp Ther; 1986 Apr; 237(1):120-5. PubMed ID: 3958961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats.
    Woolverton WL; Cervo L
    Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release.
    Carboni E; Acquas E; Frau R; Di Chiara G
    Eur J Pharmacol; 1989 May; 164(3):515-9. PubMed ID: 2767122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus (DS) properties of nicotine in the C57BL/6 mouse.
    Varvel SA; James JR; Bowen S; Rosecrans JA; Karan LD
    Pharmacol Biochem Behav; 1999 May; 63(1):27-32. PubMed ID: 10340520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the stimulus effects of morphine by d-amphetamine.
    Gaiardi M; Bartoletti M; Gubellini C; Bacchi A; Babbini M
    Pharmacol Biochem Behav; 1998 Jan; 59(1):249-53. PubMed ID: 9443562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.